Molecular Imaging of Pulmonary Nodules
- 1 March 2014
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 202 (3), W217-W223
- https://doi.org/10.2214/ajr.13.11733
Abstract
Lung nodules can be benign or malignant, reflecting many possible causes, ranging from inflammatory and infectious processes to neoplasms. Incidental detection on chest x-ray or thoracic CT often requires further evaluation by imaging or invasive procedures. Currently, 18F-FDG PET/CT offers both anatomic and metabolic characterization of lung nodules. Fluorine-18-thymidine, 11C-methionine, 68Ga-DOTA-somatostatin analogs, and 18F-dihydroxyphenylalanine may offer additional molecular information useful for diagnosis and treatment planning.Keywords
This publication has 43 references indexed in Scilit:
- Decision Making in Patients with Pulmonary NodulesAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Combined Positron Emission Tomography–Computed Tomography: The Historical PerspectiveSeminars in Ultrasound, CT and MRI, 2008
- CT Screening for Lung Cancer: Five-year Prospective ExperienceRadiology, 2005
- The Solitary Pulmonary NoduleThe New England Journal of Medicine, 2003
- Attenuation correction for a combined 3D PET/CT scannerMedical Physics, 1998
- Evaluation of the solitary pulmonary nodule by positron emission tomography imagingEuropean Respiratory Journal, 1996
- Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.Radiology, 1993
- Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.Radiology, 1993
- Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1992
- The Solitary Pulmonary NoduleAnnals of Surgery, 1958